Financial advisor vs investment advisor

Sansera Engineering | CMP: Rs 714 | The scrip fell over 7 percent after the company said one of its clients recalled Rs 3,066-crore order that was placed in April. “Regarding business contract from a leading North American OEM for development, manufacturing and supply of connecting rods starting July 2025, we would like to inform you that basis recent review of business plan/strategy, our customer has decided to drop this project, consequent to which, the contract awarded to us by the aforesaid OEM stands withdrawn,” Sansera Engineering said in a regulatory filing on July 26. PRO Only Highlights - Quarterly performance largely backed by improved realisations - Medium-term triggers China plus and protectionist measures for tyre industry - Valuations not inexpensive; but improved medium-term outlook Cummins India continues to ride on the economic recovery, both in the domestic and the export markets, despite geopolitical concerns, supply-chain issues, and … [Read more...] about Cummins India: Back on growth path; expensive valuation tempers excitement

Trade Watchlist Portfolio Message Set Alert live bse live nse live Volume Todays L/H More × Arihant Capital's research report on India Glycols India Glycols Ltd (IGL) reported strong numbers, Q1FY23 revenue stood at INR 808cr (+24.2% YoY/+25.8% QoQ); below our estimates of INR 816cr. Gross Profit stood at INR 277Cr (+40% YoY/-0.9% QoQ), Gross margins increased by 286 bps to 14.9% vs 12.0% in Q1FY22. The margin improvement mainly because of raw material cost decreased in terms of sales. The raw material cost in terms of sales stood at 65.7% vs 69.6% in Q1FY22. EBITDA stood at INR 63cr (+13.8% YoY/-21.5% QoQ); below our estimates of INR 67cr. EBITDA margin decreased by 71 bps to 7.7% vs 8.4% in Q1FY22. PAT stood at INR 28cr and PAT Margin stood at 3.4% vs -5.9% in Q1FY22. Outlook We have a “BUY’ rating at a TP of INR 1,056 per share; valued at PE multiple 10.9x and its … [Read more...] about Buy India Glycols; target of Rs 1056: Arihant Capital

Rama Steel Tubes: Nomura Singapore buys 1 lakh shares in Rama Steel Tubes. Nomura Singapore bought 1 lakh equity shares in the company via open market transactions on June 15. These shares were acquired at an average price of Rs 371 per share. Trade Watchlist Portfolio Message Set Alert live bse live nse live Volume Todays L/H More × Prabhudas Lilladher's research report on Hero Motocorp Hero’s 1QFY23 EBITDA margin at 11.2% (flat QoQ PLe: 11.7%) came below our expectations and was impacted by higher raw material costs (gross margin contraction of ~350bps QoQ). However, management expects margin expansion in the quarters ahead led by commodity cost softening, consistent price hikes and increase in volumes. It targets EBITDA margin recovery to at least 14% vs ~11% currently. Festive season is expected to be healthy on the back of normal monsoons and increase in crop prices. … [Read more...] about Buy Hero Motocorp; target of Rs 3130: Prabhudas Lilladher

Trade Watchlist Portfolio Message Set Alert live bse live nse live Volume Todays L/H More × KR Choksey's research report on Glenmark Pharma Glenmark Pharmaceuticals reported a revenue decline of 6.3% YoY (-8.0% QoQ) to INR 27,773 mn, mainly due to a fall in India revenue (37.3% of operating revenue) by 15.5% YoY (+17.0% QoQ) to INR 10,352 mn and a 15.9% YoY (-10.2% QoQ) decline in the US revenue (23.9%) to INR 6,628 mn. The decline in revenue has been on account of a high base effect due to the lack of higher sales of COVID 19 products in Q1FY23. Excluding COVID 19 sales, the revenue growth would be 10.4% YoY in Q1FY23. The company has gained market in its core therapies such as Cardiac (5.2% market share) and anti-diabetic (1.8%) and continues to be the market leader with a 2 nd rank in Dermatology, 4 th in respiratory, and 5 th in Cardiovascular therapies, in India, as of Q1FY23 … [Read more...] about Accumulate Glenmark Pharma; target of Rs 433: KR Choksey

Trade Watchlist Portfolio Message Set Alert live bse live nse live Volume Todays L/H More × Prabhudas Lilladher's research report on Apollo Hospitals Enterprise Apollo hospitals enterprises (APHS) consolidated EBITDA decline by 6% to Rs4.9bn, in line with our estimate. Adjusted for 24x7 losses, EBITDA was up 12% YoY. Hospital profitability recovered QoQ with 19% EBITDA growth while losses from 24x7 remain at elevated levels. EBITDA from offline pharmacy (SAP) and AHLL decline by 3% and 39% YoY given high base. Overall occupancy stood at 60% vs 58% in Q4. ARPOB remain healthy at Rs.51K; up 7% QoQ aided by reduction in ALOS and payor mix. Net debt reduced by Rs 2.1bn QoQ to Rs 9bn. APHS pursued aggressive expansion in past few years which has created a strong growth platform. APHS digital foray makes it a strong Omni - channel play and given strong presence in offline format makes … [Read more...] about Buy Apollo Hospitals Enterprise; target of Rs 5000: Prabhudas Lilladher

Share to Twitter Share to Linkedin The legal industry has been remarkably buoyant in a tumultuous world. It has weathered 9/11, the global financial crisis, economic downturns , automation, digital transformation , domestic and international instability, and the Pandemic. Through it all, the legal sector has prospered financially , even as its resistance to change has misaligned it with business and distanced it from society . Law’s financial success has come at a steep price—the health and well-being of its workforce, an obscured purpose, and high profits but low customer satisfaction. Public trust in lawyers , legal institutions , and the vitality of the rule have law are historically low. Most Americans believe the legal system is accessible only to the wealthy and the data confirms this. The legal system is widely perceived as lacking accessibility impartiality, transparency, diversity reflective of the society it purports to serve, … [Read more...] about Democratic Degradation Is Law’s Ultimate Disruptor

Chamath Palihapitiya - A + A NEW YORK (Aug 17): The news came with little fanfare. It was late on a sleepy summer afternoon last week, and few on Wall Street even seemed to notice the pair of filings when they hit the Securities and Exchange Commission's (SEC) website. In terse, boilerplate language, the documents stated that two special-purpose acquisition companies (SPACs) launched by Chamath Palihapitiya needed to push back the deadlines they had set to make acquisitions. Palihapitiya was in no mood to trumpet the news. There were no tweets, no interviews, none of the braggadocio that came with so many of his big SPAC deals, back when the market was the hot new thing in finance, a sure-fire, money-minting machine, and Palihapitiya was its undisputed king. But if those euphoric moments two years ago represented the peak of SPAC frenzy — a phenomenon created out of the same ingredients (unprecedented monetary and fiscal stimulus) that gave us meme stocks and … [Read more...] about US SPAC king goes silent with his empire shrivelling

The James Webb Space Telescope (JWST) started its science mission just a few weeks ago, surpassing all expectations while astonishing scientists and the public alike. Its infrared instruments and a light-collecting area 6.25 times larger than the Hubble Space Telescope are delivering sharper photos that go further into the Universe’s past than ever before. advertisement advertisement And yet, it will soon feel like a toy camera. The Webb is just the beginning of a new golden age of astronomy that is bringing us devices that will capture images that we can’t even imagine right now—the aggregate of which will change our perception of existence itself. Two of these future machines are very different from the JWST, each representing two completely different design philosophies. One is the Giant Magellan Telescope (GMT), a titanic device equipped with seven 27.5-foot mirrors that will be housed inside a 12-story building on top of Las Campanas Observatory … [Read more...] about These next-gen telescopes will make the James Webb look like a toy

- A + A KUALA LUMPUR (Aug 17): Homegrown digital solutions and application development specialist Agmo Holdings Bhd (Agmo) has plans to expand in Singapore, targetting to set-up teams within 18 months of its listing on Bursa Malaysia’s ACE Market on Thursday (Aug 18). Agmo aims to raise RM22.10 million from its initial public offering (IPO). Its chief executive officer Tan Aik Keong said with a dedicated team in the city state, Agmo will be able to focus on growing the business and enhancing its customer relationships there. “We will expand our regional footprint by venturing into Singapore, where the mobile and web application development and digital solutions industries are expected to continue on a strong growth trajectory. “The establishment of our business presence there is expected to increase the group’s profile in the region,” he told Bernama . He said Singapore is a key global financial centre and also a regional base for many technology-related … [Read more...] about Agmo to set up Singapore teams within 18 months of listing

Paul Moller stands in the back corner of a large garage in Davis, California, clean-shaven and wearing a large pair of golden aviator glasses. The 52-year-old engineer is a professor down the road at the University of California, Davis, but he’s not the type to sit back with a book and highlighter. In his white polo shirt and glossy brown bomber jacket, he looks ready to tinker with the shiny invention behind him at knee-level at a moment’s notice. advertisement advertisement The dark blue saucer behind Moller features eight propellers encircling a small, one-person cockpit. Behold Moller’s new M200X—a vehicle reminiscent of the Jetson family’s green flying car that Moller says is almost ready for manned test flights. Cut to: Moller stands outside with the M200X in an open grassy field. The vehicle, tethered to a rope, powers up, whirring loudly. The saucer lifts slowly into the air, rocking back and forth unsteadily, before Moller and his team signal … [Read more...] about Paul Moller’s 50-year dream to build a flying car won’t die